We have issued an updated research report on Colfax Corporation on Apr 11.
Exposures in emerging markets, focus on innovative products and gains from buyouts are to benefit Colfax in the years ahead. However, industry competition, rising costs and expenses remain prime concerns.
Despite solid growth opportunities that are stemming from inorganic strategies — including both acquisition of meaningful businesses and divestment of non-core assets — and healthy segmental businesses, we believe that this machinery company faces several headwinds that can jeopardize financial performance in the near-term.
The company, with $3.8 billion market capitalization, currently carries a Zacks Rank #4 (Sell). Below, we have briefly discussed the prevalent headwinds for Colfax.
Share Price Performance and Earnings Estimate Revision: In the last three months, Colfax’s shares have edged down 25.8%, worse than 7.3% decline recorded by the industry.
Also, earnings estimates of the company for both 2018 and 2019 were decreased by two brokerage firms. Currently, the Zacks Consensus Estimate is at $2.10 for 2018 and $2.34 for 2019, reflecting the decline of 0.9% and 0.8%, respectively, from the 60-day ago tallies.
Colfax Corporation Price and Consensus
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
We have issued an updated research report on Colfax Corporation on Apr 11.
Exposures in emerging markets, focus on innovative products and gains from buyouts are to benefit Colfax in the years ahead. However, industry competition, rising costs and expenses remain prime concerns.
Despite solid growth opportunities that are stemming from inorganic strategies — including both acquisition of meaningful businesses and divestment of non-core assets — and healthy segmental businesses, we believe that this machinery company faces several headwinds that can jeopardize financial performance in the near-term.
The company, with $3.8 billion market capitalization, currently carries a Zacks Rank #4 (Sell). Below, we have briefly discussed the prevalent headwinds for Colfax.
Share Price Performance and Earnings Estimate Revision: In the last three months, Colfax’s shares have edged down 25.8%, worse than 7.3% decline recorded by the industry.
Also, earnings estimates of the company for both 2018 and 2019 were decreased by two brokerage firms. Currently, the Zacks Consensus Estimate is at $2.10 for 2018 and $2.34 for 2019, reflecting the decline of 0.9% and 0.8%, respectively, from the 60-day ago tallies.
Colfax Corporation Price and Consensus
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on DOV - FREE
Get the latest research report on DXPE - FREE
Get the latest research report on KAI - FREE